Cold chain transportation of vaccines in 2025
How does cold chain transportation of vaccines work in 2025? Vaccines are delicate biological products. They lose potency when exposed to improper temperatures, so their journey from factory to clinic must stay within specific thermal ranges. Par 2025 the vaccine logistics market is projected to grow to around US$4.25 billion. Pourtant à peu près 35 % of vaccine doses are compromised due to temperature mishandling, and even one hour above +8 °C can degrade potency by about 20 %. This guide uses plain language and evidence to explain how modern cold chains protect vaccines through air, mer, land and drone transport, while complying with regulations and embracing new technologies. Why precise temperature control is nonnegotiable for vaccines and what happens when it fails. How different transport modes (air, mer, route, rail and drones) are used together and why each carries unique risks . Which packaging technologies keep vaccines safe across long journeys, including passive and active shippers. What regulations govern vaccine logistics (DSCSA, PIB, Lignes directrices de l'OMS) and their 2025...